GPhA bolsters lobbying team
The Generic Pharmaceutical Association appoints Gary Heimberg as VP-federal affairs and Jason Money as director of government affairs. Heimberg comes to GPhA from Akin Gump's public law and policy practice where he was a senior counsel; he has also worked for Sen. Edward Kennedy, D-Mass. Bruce Lott, who previously had the title of VP of government affairs, will serve as VP of state affairs. Prior to joining GPhA, Money served as health legislative assistant for Sen. George Allen, R-Va. He and Reilly O'Connor, who was recently promoted, will both serve as directors of government affairs...
You may also be interested in...
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.
Innovent Biologics has broadened its international reach by striking a licensing deal with PT Etana Biotechnologies in Indonesia for its Byvasda bevacizumab biosimilar.
Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.